Novel Chest Radiographic Biomarkers for COVID-19 Using Radiomic Features Associated with Diagnostics and Outcomes

Carregando...
Imagem de Miniatura
Citações na Scopus
15
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Citação
JOURNAL OF DIGITAL IMAGING, v.34, n.2, Special Issue, p.297-307, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
COVID-19 is a highly contagious disease that can cause severe pneumonia. Patients with pneumonia undergo chest X-rays (XR) to assess infiltrates that identify the infection. However, the radiographic characteristics of COVID-19 are similar to the other acute respiratory syndromes, hindering the imaging diagnosis. In this work, we proposed identifying quantitative/radiomic biomarkers for COVID-19 to support XR assessment of acute respiratory diseases. This retrospective study used different cohorts of 227 patients diagnosed with pneumonia; 49 of them had COVID-19. Automatically segmented images were characterized by 558 quantitative features, including gray-level histogram and matrices of co-occurrence, run-length, size zone, dependence, and neighboring gray-tone difference. Higher-order features were also calculated after applying square and wavelet transforms. Mann-Whitney U test assessed the diagnostic performance of the features, and the log-rank test assessed the prognostic value to predict Kaplan-Meier curves of overall and deterioration-free survival. Statistical analysis identified 51 independently validated radiomic features associated with COVID-19. Most of them were wavelet-transformed features; the highest performance was the small dependence matrix feature of ""low gray-level emphasis"" (area under the curve of 0.87, sensitivity of 0.85, p<0.001). Six features presented short-term prognostic value to predict overall and deterioration-free survival. The features of histogram ""mean absolute deviation"" and size zone matrix ""non-uniformity"" yielded the highest differences on Kaplan-Meier curves with a hazard ratio of 3.20 (p<0.05). The radiomic markers showed potential as quantitative measures correlated with the etiologic agent of acute infectious diseases and to stratify short-term risk of COVID-19 patients.
Palavras-chave
COVID-19, Radiomics, Coronavirus, Chest radiography, Medical image analysis
Referências
  1. Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006
  2. Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
  3. Azevedo-Marques, 2020, RADIOL BRAS
  4. Bai HX, 2020, RADIOLOGY, V296, pE46, DOI 10.1148/radiol.2020200823
  5. Bustos A, 2019, ARXIV PREPRINT ARXIV
  6. Chandra, P 3 INT C COMP VIS I, P21
  7. Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]
  8. Cohen J. P., 2020, COVID 19 IMAGE DATA
  9. Degnan AJ, 2019, ACAD RADIOL, V26, P833, DOI 10.1016/j.acra.2018.11.006
  10. Demner-Fushman D, 2016, J AM MED INFORM ASSN, V23, P304, DOI 10.1093/jamia/ocv080
  11. Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432
  12. Ferreira JR, 2020, INT J COMPUT ASS RAD, V15, P163, DOI 10.1007/s11548-019-02093-y
  13. Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169
  14. Guan CS, 2020, ACAD RADIOL, V27, P609, DOI 10.1016/j.acra.2020.03.002
  15. Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
  16. Italian Society of Medical and Interventional Radiology, 2020, COVID 19 DAT
  17. Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010
  18. Kolahdouzan, RADIOLOGY CARDIOTHOR, V2
  19. Kolossvary M, 2018, J THORAC IMAG, V33, P26, DOI 10.1097/RTI.0000000000000268
  20. Li L, RADIOLOGY
  21. Li MZ, 2020, ACAD RADIOL, V27, P603, DOI 10.1016/j.acra.2020.03.003
  22. Liang GB, 2020, COMPUT METH PROG BIO, V187, DOI 10.1016/j.cmpb.2019.06.023
  23. Liu KC, 2020, EUR J RADIOL, V126, DOI 10.1016/j.ejrad.2020.108941
  24. Ng Ming-Yen, 2020, Radiol Cardiothorac Imaging, V2, pe200034, DOI 10.1148/ryct.2020200034
  25. Pazhitnykh I., 2017, LUNG SEGMENTATION 2D
  26. Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial, 2020, LOW COST DEX RED DEA
  27. Ronneberger O., 2015, P INT C MEDICAL IMAG, P234
  28. Santos Marcel Koenigkam, 2019, Radiol Bras, V52, P387, DOI 10.1590/0100-3984.2019.0049
  29. Sousa RT, 2013, PROCEDIA COMPUT SCI, V18, P2579, DOI 10.1016/j.procs.2013.05.444
  30. van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339
  31. Yuan ML, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230548
  32. Zwanenburg A, 2020, RADIOLOGY, V295, P328, DOI 10.1148/radiol.2020191145